VALSECCHI MARIA GRAZIA

Bugarin, C., Antolini, L., Buracchi, C., Matarraz, S., Coliva, T., Van der Velden, V., et al. (2024). Phenotypic profiling of CD34+ cells by advanced flow cytometry improves diagnosis of Juvenile Myelomonocytic Leukemia. HAEMATOLOGICA, 109(2 (February, 2024)), 521-532 [10.3324/haematol.2023.282805]. Detail

Faverio, P., Paciocco, G., Tassistro, E., Rebora, P., Rossi, E., Monzani, A., et al. (2024). Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study. INTERNAL AND EMERGENCY MEDICINE, 19(1 (January 2024)), 183-190 [10.1007/s11739-023-03400-x]. Detail

Risca, G., Capitoli, G., Rotolo, F., Galimberti, S., Valsecchi, M. (2023). Validation of a skewed surrogate endpoint for a time-to-event outcome: the use of a Zaga distribution. Intervento presentato a: ISCB44, Milan, Italy. Detail

Kanai, M., Andrews, S., Cordioli, M., Stevens, C., Neale, B., Daly, M., et al. (2023). A second update on mapping the human genetic architecture of COVID-19. NATURE, 621(7977), 7-26 [10.1038/s41586-023-06355-3]. Detail

Moricke, A., Rizzari, C., Alten, J., Attarbaschi, A., Beier, R., Biondi, A., et al. (2023). Hypersensitivity Reactions to Native E. coli L-asparaginase in Children with Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction. HEMASPHERE, 7(6), 888-890 [10.1097/HS9.0000000000000888]. Detail